Actively Recruiting
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor
Led by Baker Heart and Diabetes Institute · Updated on 2024-08-12
168
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure. This program aims to improve cognition, reduce dementia risk and cardiovascular events, and will be supported by innovative digital technology for wide scale rollout and implementation. Findings from this research will transform the way healthcare is delivered to cognitively impaired patients with heart disease who have a very high risk of developing dementia.
CONDITIONS
Official Title
Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized with heart failure as primary or secondary diagnosis
- At least mild cognitive impairment based on Montreal Cognitive Assessment (MoCA) on hospital discharge
You will not qualify if you...
- Unable to provide written consent; requiring palliative care; or participating in another randomized clinical trial
- Recovery of cognitive function shortly after hospital discharge (MoCA score greater than 25 at 2 weeks post-discharge)
- Terminal illness (e.g., cancer) that may affect 12-month prognosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Menzies Institute for Medical Research
Hobart, Tasmania, Australia, 7000
Actively Recruiting
Research Team
Q
Quan Huynh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here